Dan Roden
Faculty Member
Last active: 3/24/2020

  1. Size matters: how population size influences genotype-phenotype association studies in anonymized data. Heatherly R, Denny JC, Haines JL, Roden DM, Malin BA (2014) J Biomed Inform : 243-50
    › Primary publication · 25038554 (PubMed) · PMC4260994 (PubMed Central)
  2. Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current. Yang T, Chun YW, Stroud DM, Mosley JD, Knollmann BC, Hong C, Roden DM (2014) Circulation 130(3): 224-34
    › Primary publication · 24895457 (PubMed) · PMC4101031 (PubMed Central)
  3. SCN10A/Nav1.8 modulation of peak and late sodium currents in patients with early onset atrial fibrillation. Savio-Galimberti E, Weeke P, Muhammad R, Blair M, Ansari S, Short L, Atack TC, Kor K, Vanoye CG, Olesen MS, LuCamp , Yang T, George AL, Roden DM, Darbar D (2014) Cardiovasc Res 104(2): 355-63
    › Primary publication · 25053638 (PubMed) · PMC4271018 (PubMed Central)
  4. Rheumatoid arthritis is associated with IgG antibodies to human endogenous retrovirus gag matrix: a potential pathogenic mechanism of disease? Nelson PN, Roden D, Nevill A, Freimanis GL, Trela M, Ejtehadi HD, Bowman S, Axford J, Veitch AM, Tugnet N, Rylance PB (2014) J Rheumatol 41(10): 1952-60
    › Primary publication · 25225282 (PubMed)
  5. Response to "clinically actionable genotypes among Brazilians". Van Driest SL, Roden DM (2014) Clin Pharmacol Ther 96(1): 26
    › Primary publication · 24682028 (PubMed)
  6. Replication of Associations with Electrocardio-graphic Traits in African Americans from Clinical and Epidemiologic Studies. Jeff JM, Brown-Gentry K, Goodloe R, Ritchie MD, Denny JC, Kho AN, Armstrong LL, McClellan B, Mayo P, Allen M, Jin H, Gillani NB, Schnetz-Boutaud N, Dilks HH, Basford MA, Pacheco JA, Jarvik GP, Chisholm RL, Roden DM, Hayes MG, Crawford DC (2014) Evol Comput Mach Learn Data Min Bioinform : 939-951
    › Primary publication · 25590050 (PubMed) · PMC4290789 (PubMed Central)
  7. Phenome-wide association studies demonstrating pleiotropy of genetic variants within FTO with and without adjustment for body mass index. Cronin RM, Field JR, Bradford Y, Shaffer CM, Carroll RJ, Mosley JD, Bastarache L, Edwards TL, Hebbring SJ, Lin S, Hindorff LA, Crane PK, Pendergrass SA, Ritchie MD, Crawford DC, Pathak J, Bielinski SJ, Carrell DS, Crosslin DR, Ledbetter DH, Carey DJ, Tromp G, Williams MS, Larson EB, Jarvik GP, Peissig PL, Brilliant MH, McCarty CA, Chute CG, Kullo IJ, Bottinger E, Chisholm R, Smith ME, Roden DM, Denny JC (2014) Front Genet : 250
    › Primary publication · 25177340 (PubMed) · PMC4134007 (PubMed Central)
  8. Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs. Roden DM (2014) Card Electrophysiol Clin 6(4): 695-704
    › Primary publication · 25395995 (PubMed) · PMC4226533 (PubMed Central)
  9. Personalized medicine to treat arrhythmias. Roden DM (2014) Curr Opin Pharmacol : 61-7
    › Primary publication · 24721655 (PubMed) · PMC3984450 (PubMed Central)
  10. Integrating EMR-linked and in vivo functional genetic data to identify new genotype-phenotype associations. Mosley JD, Van Driest SL, Weeke PE, Delaney JT, Wells QS, Bastarache L, Roden DM, Denny JC (2014) PLoS One 9(6): e100322
    › Primary publication · 24949630 (PubMed) · PMC4065041 (PubMed Central)